Coronavirus: Govt bans export of face masks and ventilators

NEW DELHI: The central government has banned the export of surgical face masks, the textile material that goes into making the masks and covers along with ventilators and respirators as it seeks to ensure adequate supply of the critical materials at a time when the coronavirus count is rising in the country.

The availability of these masks has become difficult with sellers accusing raw material suppliers of raising prices, resulting in higher cost for the consumer. In any case, there has been panic buying of these masks despite repeated assurances from the government that there is no need to sport them unnecessarily.

Behind Imposing ban on export of the material used for making the masks, government is trying to increase more supplies available in the domestic market and rein in prices.

Similarly, in case of ventilators, there is rise in the demand globally with the UK asking companies such as Rolls Royce, Ford and other car companies to manufacture the critical care equipment that assists in breathing.

Since India imports a large part of its requirements, the government wants to ensure that domestic manufacturers do not export whatever supplies are available in the country.

  • Related Posts

    How much of Healthcare Research reaches Bedside in India? Or gets Lost in Translation?

    BMJ Research Forum all set to mull over in Delhi on September 5 New Delhi: Research in healthcare in India is a dime a dozen. But the real question that…

    Former Advisor to India’s Union Health Ministry gets Quite a Feather in his Cap

    Dr Rajendra Pratap Gupta gets nominated to advise UN Secretary General Geneva/ New Delhi: Former advisor to Union Health Minister of India JP Nadda in his earlier stint and a…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    Yashoda Medicity Successfully Performs High-Risk Kidney Transplant in 28-Year- Old Woman

    Yashoda Medicity Successfully Performs High-Risk Kidney Transplant in 28-Year- Old Woman

    Avacta delivers two clinical stage peptide-drug conjugates to target delivery of toxic payloads into the tumour microenvironment

    Avacta delivers two clinical stage peptide-drug conjugates to target delivery of toxic payloads into the tumour microenvironment

    US FDA approves first gene therapy for paediatric patients with Sanfilippo syndrome type A

    US FDA approves first gene therapy for paediatric patients with Sanfilippo syndrome type A

    Technology and accessibility are key to growth of advanced treatment of heart diseases, says expert

    Technology and accessibility are key to growth of advanced treatment of heart diseases, says expert

    Puresta launches EVERQ, AI-powered skin-health platform

    Puresta launches EVERQ, AI-powered skin-health platform

    Stem cell therapy for autism only in approved clinical trials: Centre

    Stem cell therapy for autism only in approved clinical trials: Centre